Event-Driven Stocks

Cardio Diagnostics Holdings, Inc.

CDIONasdaq

Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21
Revenue$14,825$34,890$17,065$950$901
Operating income−$6.5M−$8.4M−$7.2M−$4.5M−$620,448
Net income−$6.5M−$8.4M−$8.4M−$4.7M−$620,448
Total assets$7.8M$10.6M$4.5M$6.2M$1.1M
Total liabilities$793,061$1.1M$1.5M$1.9M$33,885
Equity$7.0M$9.6M$3.0M$4.3M$1.1M
EPS (diluted)$-3.71$-9.35$-0.66$-1.51$-0.53
Shares out.52.1M21.6M9.6M8.1M1.2M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−43737.5%
Net margin
−43832.5%
Return on equity
−93.2%
Return on assets
−83.7%
Return on capital (ROCE)
−90.5%
Liabilities / assets
10.2%
Debt / equity
0.11×
Book value / share
$0.13
Revenue growth (YoY)
−57.5%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-4.17distress
Accruals / assets
−9.9%clean
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
35
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202619,0001.0-59.4%
Apr 30, 202646,8151.2-12.9%
Apr 15, 202653,7611.0+141.5%
Mar 31, 202622,2641.0-86.1%
Mar 13, 2026160,5441.0-68.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)